Literature DB >> 22833830

Predicting survival of patients with resectable non-small cell lung cancer: Beyond TNM.

Raymond U Osarogiagbon1.   

Abstract

Entities:  

Year:  2012        PMID： 22833830      PMCID： PMC3378237          DOI： 10.3978/j.issn.2072-1439.2012.03.06

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

1.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

2.  Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?

Authors:  Shenhai Wei; Hisao Asamura; Riken Kawachi; Hiroyuki Sakurai; Shun-ichi Watanabe
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

3.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

4.  Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Joe B Putnam
Journal:  Chest       Date:  2010-09-09       Impact factor: 9.410

5.  Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial.

Authors:  Valerie W Rusch; Debra Hawes; Paul A Decker; Sue Ellen Martin; Andrea Abati; Rodney J Landreneau; G Alexander Patterson; Richard I Inculet; David R Jones; Richard A Malthaner; Robbin G Cohen; Karla Ballman; Joe B Putnam; Richard J Cote
Journal:  J Clin Oncol       Date:  2011-10-11       Impact factor: 44.544

6.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

7.  Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.

Authors:  John M Varlotto; Abram Recht; Margaret Nikolov; John C Flickinger; Malcolm M Decamp
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

8.  Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.

Authors:  Sai-Hong Ignatius Ou; Jason A Zell
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

9.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Authors:  Giorgio Vittorio Scagliotti; Purvish Parikh; Joachim von Pawel; Bonne Biesma; Johan Vansteenkiste; Christian Manegold; Piotr Serwatowski; Ulrich Gatzemeier; Raghunadharao Digumarti; Mauro Zukin; Jin S Lee; Anders Mellemgaard; Keunchil Park; Shehkar Patil; Janusz Rolski; Tuncay Goksel; Filippo de Marinis; Lorinda Simms; Katherine P Sugarman; David Gandara
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

10.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Authors:  David H Johnson; Louis Fehrenbacher; William F Novotny; Roy S Herbst; John J Nemunaitis; David M Jablons; Corey J Langer; Russell F DeVore; Jacques Gaudreault; Lisa A Damico; Eric Holmgren; Fairooz Kabbinavar
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
View more
  15 in total

1.  A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System.

Authors:  Jie Lin; Corey A Carter; Katherine A McGlynn; Shelia H Zahm; Joel A Nations; William F Anderson; Craig D Shriver; Kangmin Zhu
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

2.  PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.

Authors:  Ze-Jun Zhou; Ping Zhan; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2015-04

3.  Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis.

Authors:  Xiao-Bin Wang; Jie Li; Yi Han
Journal:  Tumour Biol       Date:  2014-07-15

4.  Improving post-resection risk stratification in non-small cell lung cancer: 'wit, whither wander you?'

Authors:  Raymond U Osarogiagbon
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Ransome Eke; Srishti Sareen; Cynthia Leary; LaShundra Coleman; Nicholas Faris; Xinhua Yu; David Spencer
Journal:  Ann Diagn Pathol       Date:  2014-04-26       Impact factor: 2.090

6.  Improving the pathologic evaluation of lung cancer resection specimens.

Authors:  Raymond U Osarogiagbon; Holly L Hilsenbeck; Elizabeth W Sales; Allen Berry; Robert W Jarrett; Christopher S Giampapa; Clara N Finch-Cruz; David Spencer
Journal:  Transl Lung Cancer Res       Date:  2015-08

7.  Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

8.  Squamous cell carcinoma of pancreas: an unusual site of relapse from early-stage lung cancer: 12-month postsurgery.

Authors:  Anand Sharma; Maryam Alfa-Wali; Manuel Rodriguez-Justo; Andreas Polychronis
Journal:  BMJ Case Rep       Date:  2013-04-22

9.  Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma.

Authors:  Rolandas Zablockis; Edvardas Žurauskas; Edvardas Danila; Vygantas Gruslys
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

10.  Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.

Authors:  Matthew P Smeltzer; Nicholas R Faris; Meredith A Ray; Raymond U Osarogiagbon
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.